114 related articles for article (PubMed ID: 228691)
1. Evaluation of leucocyte adherence inhibition in hepatocellular carcinoma.
Dusheiko GM; Kew MC; Rabson AR
Br J Cancer; 1979 Sep; 40(3):397-402. PubMed ID: 228691
[TBL] [Abstract][Full Text] [Related]
2. Leucocyte adherence inhibition assay for immunodiagnosis of hepatocellular carcinoma.
Onji M
Gastroenterol Jpn; 1984 Aug; 19(4):336-43. PubMed ID: 6092190
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of leukocyte adherence inhibition (LAI) test in primary and secondary hepatic malignancies.
Tantry BV; Jain AK; Gupta S; Gupta JP
J Surg Oncol; 1984 Nov; 27(3):159-62. PubMed ID: 6092784
[TBL] [Abstract][Full Text] [Related]
4. A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay.
O'Connor R; MacFarlane JK; Murray D; Thomson DM
Br J Cancer; 1978 Dec; 38(6):674-84. PubMed ID: 369586
[TBL] [Abstract][Full Text] [Related]
5. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
[TBL] [Abstract][Full Text] [Related]
6. [The diagnostic value of leukocyte adherence inhibition test for primary heptocellular carcinoma].
Liu GQ
Zhonghua Nei Ke Za Zhi; 1984 Feb; 23(2):87-90. PubMed ID: 6205833
[No Abstract] [Full Text] [Related]
7. Value of serum alpha-fetoprotein and ferritin in the diagnosis of hepatocellular carcinoma.
Tatsuta M; Yamamura H; Iishi H; Kasugai H; Okuda S
Oncology; 1986; 43(5):306-10. PubMed ID: 2429242
[TBL] [Abstract][Full Text] [Related]
8. Alpha-fetoprotein reaction to Pisum sativum agglutinin in differentiation of benign liver diseases from hepatocellular carcinoma.
Yin ZF; Tu ZX; Cui ZF; Wu MC
Chin Med J (Engl); 1993 Aug; 106(8):615-8. PubMed ID: 7693403
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of alpha-1-antitrypsin in the diagnosis of hepatocellular carcinoma.
Hong WS; Hong SI
J Korean Med Sci; 1991 Sep; 6(3):206-13. PubMed ID: 1663767
[TBL] [Abstract][Full Text] [Related]
10. Added Value of a Gadoxetic Acid-enhanced Hepatocyte-phase Image to the LI-RADS System for Diagnosing Hepatocellular Carcinoma.
Chen N; Motosugi U; Morisaka H; Ichikawa S; Sano K; Ichikawa T; Matsuda M; Fujii H; Onishi H
Magn Reson Med Sci; 2016; 15(1):49-59. PubMed ID: 26104079
[TBL] [Abstract][Full Text] [Related]
11. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria.
Leoni S; Piscaglia F; Golfieri R; Camaggi V; Vidili G; Pini P; Bolondi L
Am J Gastroenterol; 2010 Mar; 105(3):599-609. PubMed ID: 19935786
[TBL] [Abstract][Full Text] [Related]
12. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
Ho CL; Yu SC; Yeung DW
J Nucl Med; 2003 Feb; 44(2):213-21. PubMed ID: 12571212
[TBL] [Abstract][Full Text] [Related]
13. Specific immunodiagnosis of hepatocellular carcinoma by leucocyte adherence inhibition.
Halliday WJ; Halliday JW; Campbell CB; Maluish AE; Powell LW
Br Med J; 1974 May; 2(5915):349-52. PubMed ID: 4365124
[TBL] [Abstract][Full Text] [Related]
14. [Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
Li J; Wei L
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):246-50. PubMed ID: 24915815
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic role of glypican 3 and CD34 for differentiating hepatocellular carcinoma from nonmalignant hepatocellular lesions.
Enan ET; El-Hawary AK; El-Tantawy DA; Abu-Hashim MM; Helal NM
Ann Diagn Pathol; 2013 Dec; 17(6):490-3. PubMed ID: 24012547
[TBL] [Abstract][Full Text] [Related]
16. Characterizing the Risk of False-Positive Hepatocellular Carcinoma in Recipients Transplanted With T2 MELD Exceptions.
Bittermann T; Goldberg DS; Bauer CM; Khungar V
Transplantation; 2017 May; 101(5):1099-1105. PubMed ID: 28121908
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy.
Wang FH; Yip YC; Zhang M; Vong HT; Chan KI; Wai KC; Wen JM
J Clin Pathol; 2010 Jul; 63(7):599-603. PubMed ID: 20501450
[TBL] [Abstract][Full Text] [Related]
18. 5'-Nucleotide phosphodiesterase isozyme-V in hepatocellular carcinoma and other liver diseases.
Fujiyama S; Tsude K; Sakai M; Sato T
Hepatogastroenterology; 1990 Oct; 37(5):469-73. PubMed ID: 1701410
[TBL] [Abstract][Full Text] [Related]
19. False Positive Diagnosis of Hepatocellular Carcinoma in Liver Resection Patients.
Lee H; Yoon JH; Kim H; Yi NJ; Hong SK; Yoon KC; Kim HS; Ahn SW; Choi JY; Choi Y; Lee HW; Yi JY; Lee KB; Lee KW; Suh KS
J Korean Med Sci; 2017 Feb; 32(2):315-320. PubMed ID: 28049244
[TBL] [Abstract][Full Text] [Related]
20. [Alphafetoprotein in hepatic tumours and benign liver diseases].
Forones NM; Queiroz LA; Ferraz ML; Parise ER
Rev Assoc Med Bras (1992); 1995; 41(2):91-3. PubMed ID: 8520603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
